Exhibit 99.1

 

Cadre Holdings Reports Third Quarter 2021 Financial Results

 

Expanded Gross Profit Margin and Adjusted EBITDA Margin

 

Completed Initial Public Offering, Raising Gross Proceeds of $89.7 million; Announced Quarterly Cash Dividend

 

JACKSONVILLE, Fla., December 2, 2021 – Cadre Holdings, Inc. (NYSE: CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced today its consolidated operating results for the three and nine months ended

September 30, 2021.

 

Third Quarter and Nine Month 2021 Highlights

 

·Net sales of $98.7 million for the third quarter; net sales of $323.8 million for the nine months ended September 30, 2021
·Gross profit margin of 39.8% for the third quarter; gross profit margin of 40.6% for the nine months ended September 30, 2021
·Net loss of $5.3 million, or $0.19 per share, for the third quarter; net income of $8.4 million, or $0.30 per share, for the nine months ended September 30, 2021. Both periods reflect a $15.2 million loss on the extinguishment of debt incurred from the execution of a new credit agreement
·Adjusted EBITDA of $15.4 million for the third quarter; Adjusted EBITDA of $56.1 million for the nine months ended September 30, 2021
·Cadre generated LTM Adjusted EBITDA of $71.6 million for the period ended September 30, 2021
·Adjusted EBITDA margin of 15.6% for the third quarter; Adjusted EBITDA margin of 17.3% for the nine months ended September 30, 2021
·Declared quarterly cash dividend of $0.08 per share in November 2021

 

“Our third quarter and year to date 2021 financial results highlight Cadre’s ongoing success capitalizing on our leading positions in large and growing markets with recurring demand characteristics, as well our ability to generate strong operating cash flow,” said Warren Kanders, CEO and Chairman. “We continue to build on Cadre’s impressive track record of margin expansion and have improved gross profit and Adjusted EBITDA margins in the year to date period by 250 and 300 basis points, respectively.”

 

Mr. Kanders continued, “With the recent completion of our successful IPO, we have achieved an important milestone in our company’s storied history that dates back over 55 years. We believe that we are in a strong position to take advantage of the attractive tailwinds driving demand for Cadre’s mission critical first responder products, as we focus on seeking to accelerate growth organically, as well as through our robust acquisition pipeline. As part of our disciplined capital allocation approach, we are also pleased to have implemented a regular quarterly dividend policy.”

 

Third Quarter and Nine Month 2021 Operating Results

 

For the quarter ended September 30, 2021, Cadre generated net sales of $98.7 million, as compared to $105.7 million for the quarter ended September 30, 2020.

 

For the nine months ended September 30, 2021, Cadre generated net sales of $323.8 million, as compared to $297.0 million for the nine months ended September 30, 2020.

 

For the quarter ended September 30, 2021, Cadre generated gross profit of $39.3 million, as compared to $40.0 million for the prior year period. For the nine months ended September 30, 2021, Cadre generated gross profit of $131.5 million, as compared to $113.2 million for the prior year period.

Gross profit margin was 39.8% for the quarter ended September 30, 2021, as compared to 37.8% for the prior year period, mainly driven by favorable pricing and product mix.

 

 

 

 

Gross profit margin was 40.6% for the nine months ended September 30, 2021, as compared to 38.1% for the prior year period, mainly driven by favorable pricing and product mix.

 

Net loss was $5.3 million for the quarter ended September 30, 2021, as compared to net income of $6.4 million for the three months ended September 30, 2020, primarily as a result of a loss on extinguishment of debt of $15.2 million in connection with the execution of a new credit agreement during the quarter ended September 30, 2021.

 

Net income was $8.4 million for the nine months ended September 30, 2021, as compared to $22.7 million for the nine months ended September 30, 2020, primarily as a result of a loss on extinguishment of debt, an increase in provision for income taxes due to the release of a valuation allowance on a portion of the Company’s deferred tax assets in December 2020 and non-recurring transactions recognized in the period ended September 30, 2020, offset by improvements in gross profit due to increased sales, favorable pricing and product mix.

 

Cadre generated $15.4 million of Adjusted EBITDA for the quarter ended September 30, 2021, as compared to $15.0 million for the quarter ended September 30, 2020. Adjusted EBITDA margin was 15.6% for the quarter ended September 30, 2021, as compared to 14.2% for the prior year period,

 

Cadre generated $56.1 million of Adjusted EBITDA for the nine months ended September 30, 2021, as compared to $42.5 million for the prior year period. Adjusted EBITDA margin was 17.3% for the nine months ended September 30, 2021, as compared to 14.3% for the prior year period.

 

Product segment gross margin was 40.5% for the third quarter and 41.6% for the nine months ended September 30, 2021.

 

Distribution segment gross margin was 24.6% for the third quarter and 25.2% for the nine months ended September 30, 2021.

 

Liquidity, Cash Flows and Capital Allocation

 

Cadre’s cash and cash equivalents increased by $12.4 million from $2.9 million as of December 31, 2020, to $15.3 million as of September 30, 2021. Capital expenditures totaled $0.7 million for the third quarter and $2.2 million for the nine months ended September 30, 2021, compared with $1.3 million for the third quarter and $3.9 million for the nine months ended September 30, 2020. Net debt increased by $13.1 million from $212.8 million as of December 31, 2020, to $225.9 million as of September 30, 2021.

 

During the quarter, the Company refinanced its existing credit facilities and closed on a new credit agreement that included a term loan, under which Cadre borrowed $200 million, and may borrow up to $100 million under a revolving credit facility. Both loans mature on July 23, 2026.

 

On November 3, 2021, the Company completed the closing of its initial public offering (“IPO”) of 6.9 million shares, including the full exercise of the underwriters’ option, at a price to the public of $13.00 per share, for net proceeds of approximately $78.3 million.

 

On November 9, 2021, the Company utilized proceeds received in connection with the IPO and repaid $38.9 million and $20.5 million, respectively, of borrowings outstanding under its current term loan and revolving credit facility.

 

 

 

 

Dividend

 

On November 11, 2021, the Company announced that its Board of Directors approved the initiation of a quarterly cash dividend policy of $0.08 per share of the Company’s common stock or $0.32 per share on an annualized basis. Cadre's first dividend payment will be made on December 7, 2021, to shareholders of record as of the close of business on November 22, 2021. The declaration of any future dividend is subject to the discretion of the Company’s Board of Directors.

 

Conference Call

 

Cadre management will host a conference call on Thursday, December 2, 2021, at 5:00 PM EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (844)-200-6205 and the dial-in number for international callers is (929)-526-1599. The access code for all callers is 996677. A live webcast will also be available on the Company’s website at https://www.cadre-holdings.com/.

 

A replay of the call will be available through December 16, 2021. To access the replay, please dial 866 813 9403 in the U.S. or +44 204 525 0658 if outside the U.S., and then enter the access code 515899.

 

About Cadre

 

Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety and survivability products for first responders. Cadre’s equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company’s core products include body armor, explosive ordnance disposal equipment, and duty gear. Our highly engineered products are utilized by domestic and international first responders in state and local law enforcement, fire and rescue, explosive ordnance disposal, emergency medical technicians, as well as numerous federal agencies and foreign government agencies in 104 countries. Our key brands include Safariland® and Med-Eng®, amongst others.

 

Use of Non-GAAP Measures

 

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). This press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization (“EBITDA”), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin, and (iv) LTM adjusted EBITDA . The Company believes that the presentation of certain non-GAAP measures, i.e.: (i) EBITDA, (ii) adjusted EBITDA, (iii) adjusted EBITDA margin, and (iv) LTM adjusted EBITDA, provide useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

 

Forward-Looking Statements

 

Except for historical information, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to all projections and anticipated levels of future performance. Forward-looking statements involve risks, uncertainties and other factors that may cause our actual results to differ materially from those discussed herein. Any number of factors could cause actual results to differ materially from projections or forward-looking statements, including without limitation global economic conditions, spending patterns of government agencies, competitive pressures, the impact of acquisitions and related integration activities, product liability claims, the success of new product introductions, currency exchange rate fluctuations and the risks of doing business in in the markets in which we operate, including foreign countries. More information on potential factors that could affect the Company's financial results are more fully described in our prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on November 5, 2021, and will be included from time to time in the Company's public reports filed with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.

 

 

 

 

Contact:

Gray Hudkins
Cadre Holdings, Inc.
203-550-7148

gray.hudkins@cadre-holdings.com

 

Investor Relations:

The IGB Group

Leon Berman / Matt Berkowitz

212-477-8438 / 212-227-7098

lberman@igbir.com / mberkowitz@igbir.com

 

Media Contact:

Jonathan Keehner / Andrew Siegel

Joele Frank, Wilkinson Brimmer Katcher

212-355-4449

 

 

 

 

CADRE HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts) 

 

   September 30, 2021   December 31, 2020 
Assets          
Current assets          
Cash and cash equivalents  $15,275   $2,873 
Accounts receivable, net of allowance for doubtful accounts of $624 and $1,113, respectively   42,230    43,646 
Inventories   71,067    60,923 
Prepaid expenses   9,212    6,665 
Other current assets   5,859    3,362 
           
Total current assets   143,643    117,469 
           
Property and equipment, net of accumulated depreciation and amortization of $37,510 and $33,643, respectively   33,780    35,437 
Deferred tax assets, net   11,696    12,900 
Intangible assets, net   44,459    51,009 
Goodwill   66,227    66,314 
Other assets   2,219    150 
           
Total assets  $302,024   $283,279 
           
Liabilities, Mezzanine Equity and Shareholders' Equity          
Current liabilities          
Accounts payable  $21,890   $21,978 
Accrued liabilities   40,238    36,004 
Income tax payable   2,505    1,005 
Current portion of long-term debt   12,904    3,496 
           
Total current liabilities   77,537    62,483 
           
Long-term debt   212,946    209,310 
Deferred tax liabilities   2,430    2,085 
Other liabilities   1,774    550 
           
Total liabilities   294,687    274,428 
           
Mezzanine equity          
Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2021 and December 31, 2020)        
           
Shareholders' equity          
Common stock ($0.0001 par value, 190,000,000 shares authorized, 27,483,350 issued and outstanding as of September 30, 2021 and December 31, 2020)   3    3 
Additional paid-in capital   48,670    48,670 
Accumulated other comprehensive loss   (2,747)   (2,860)
Accumulated deficit   (38,589)   (36,962)
           
Total shareholders’ equity   7,337    8,851 
           
Total liabilities, mezzanine equity and shareholders' equity  $302,024   $283,279 

 

 

 

 

CADRE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except share and per share amounts)

 

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2021   2020   2021   2020 
Net sales  $98,654   $105,735   $323,751   $297,019 
Cost of goods sold   59,346    65,739    192,256    183,869 
Gross profit   39,308    39,996    131,495    113,150 
                     
Operating expenses                    
Selling, general and administrative   27,673    26,908    87,168    79,963 
Restructuring and transaction costs   (49)   171    1,491    3,143 
Related party expense   142    159    437    480 
Other general income               (10,950)
Total operating expenses   27,766    27,238    89,096    72,636 
Operating income   11,542    12,758    42,399    40,514 
Other expense                    
Interest expense   (3,464)   (5,668)   (14,129)   (18,275)
Loss on extinguishment of debt   (15,155)       (15,155)    
Other (expense) income, net   (352)   (213)   (881)   1,925 
                     
Total other expense, net   (18,971)   (5,881)   (30,165)   (16,350)
                     
(Loss) income before provision for income taxes   (7,429)   6,877    12,234    24,164 
Benefit (provision) for income taxes   2,123    (430)   (3,861)   (1,491)
                     
Net (loss) income  $(5,306)  $6,447   $8,373   $22,673 
                     
Net (loss) income per share:                    
Basic  $(0.19)  $0.23   $0.30   $0.82 
Diluted  $(0.19)  $0.23   $0.30   $0.82 
Weighted average shares outstanding:                    
Basic   27,483,350    27,483,350    27,483,350    27,483,350 
Diluted   27,483,350    27,483,350    27,483,350    27,483,350 

 

 

 

 

CADRE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

   Nine Months Ended September 30, 
   2021   2020 
Cash Flows From Operating Activities:          
Net income  $8,373   $22,673 
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization   10,426    11,207 
Amortization of original issue discount and debt issue costs   2,483    1,012 
Loss on extinguishment of debt   15,155     
Non cash consideration received from sale of business       (6,821)
Deferred income taxes   1,533    125 
Gain on sale of fixed assets       (6,218)
Provision for losses on accounts receivable   (254)   (130)
Foreign exchange loss (gain)   45    (752)
Changes in operating assets and liabilities:          
Accounts receivable   1,549    10,922 
Inventories   (10,261)   (4,902)
Prepaid expenses and other assets   (4,642)   (2,332)
Accounts payable and other liabilities   6,582    3,408 
Net cash provided by operating activities   30,989    28,192 
Cash Flows From Investing Activities:          
Purchase of property and equipment   (2,225)   (3,913)
Proceeds from disposition of property and equipment       12,386 
Proceeds from sale of equity securities       5,591 
Net cash (used in) provided by investing activities   (2,225)   14,064 
Cash Flows From Financing Activities:          
Proceeds from revolving credit facilities   248,000    281,730 
Principal payments on revolving credit facilities   (223,132)   (283,887)
Proceeds from term loans   198,735     
Principal payments on term loans   (224,547)   (40,841)
Proceeds from insurance premium financing   4,269    2,733 
Principal payments on insurance premium financing   (2,611)   (1,998)
Payment of capital leases   (32)   (35)
Payments for debt issuance costs   (2,830)    
Payments on extinguishment of debt   (4,215)    
Dividends distributed   (9,996)    
Net cash used in financing activities   (16,359)   (42,298)
Effect of foreign exchange rates on cash and cash equivalents   (3)   6 
Change in cash and cash equivalents   12,402    (36)
Cash and cash equivalents, beginning of period   2,873    2,520 
Cash and cash equivalents, end of period   15,275    2,484 

 

 

 

 

CADRE HOLDINGS, INC.

SEGMENT INFORMATION

(Unaudited)

(In thousands)

 

   Three months ended September 30, 2021 
           Reconciling     
   Products   Distribution    Items(1)   Total 
Net sales  $83,918   $21,507   $(6,771)  $98,654 
Cost of goods sold   49,896    16,220    (6,770)   59,346 
Gross profit  $34,022   $5,287   $(1)  $39,308 

 

   Three months ended September 30, 2020 
           Reconciling     
   Products   Distribution    Items(1)   Total 
Net sales  $88,858   $23,690   $(6,813)  $105,735 
Cost of goods sold   54,325    18,273    (6,859)   65,739 
Gross profit  $34,533   $5,417   $46   $39,996 

 

   Nine months ended September 30, 2021 
           Reconciling     
   Products   Distribution    Items(1)   Total 
Net sales  $274,039   $69,086   $(19,374)  $323,751 
Cost of goods sold   159,924    51,696    (19,364)   192,256 
Gross profit  $114,115   $17,390   $(10)  $131,495 

 

   Nine months ended September 30, 2020 
           Reconciling     
   Products   Distribution    Items(1)   Total 
Net sales  $251,441   $62,707   $(17,129)  $297,019 
Cost of goods sold   153,233    47,897    (17,261)   183,869 
Gross profit  $98,208   $14,810   $132   $113,150 

(1) Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

 

 

 

 

CADRE HOLDINGS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands)

 

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2021   2020   2021   2020 
(in thousands)                
Net (loss) income  $(5,306)  $6,447   $8,373   $22,673 
Add back:                    
Depreciation and amortization   3,406    3,537    10,426    11,207 
Interest expense   3,464    5,668    14,129    18,275 
Provision for income taxes   (2,123)   430    3,861    1,491 
EBITDA  $(559)  $16,082   $36,789   $53,646 
Add back:                    
Restructuring and transaction costs(1)   (49)   171    1,491    3,143 
Other general income(2)               (10,950)
Loss on extinguishment of debt(3)   15,155        15,155     
Other (expense) income, net(4)   352    213    881    (1,925)
Contingent consideration(5)       (1,427)       (1,427)
LTIP bonus(6)   520        1,804     
Adjusted EBITDA  $15,419   $15,039   $56,120   $42,487 
Less: Capital expenditures   (719)   (1,275)   (2,225)   (3,913)
Adjusted EBITDA less capital expenditures  $14,700   $13,764   $53,895   $38,574 
Adjusted EBITDA conversion rate   95%   92%   96%   91%
Adjusted EBITDA margin   15.6%   14.2%   17.3%   14.3%

 


(1)Reflects the “Restructuring and transaction costs” line item on our consolidated statement of operations, which primarily includes transaction costs composed of legal and consulting fees.

 

(2)Reflects the “Other general income” line item on our consolidated statement of operations and includes a gain from a long-lived asset sale as well as earn-out stock payments for the nine months ended September 30, 2020.

 

(3)Reflects a loss incurred in connection with the August 2021 debt refinance.

 

(4)Reflects the “Other (expense) income, net” line item on our consolidated statement of operations. For the three and nine months ended September 30, 2021, other (expense) income, net primarily includes losses on foreign currency transactions. For the three and nine months ended September 30, 2020, other (expense) income, net primarily includes gains on foreign exchange transactions and unrealized gains on an investment in equity securities.

 

(5)Reflects a gain on the settlement of contingent consideration.

 

(6)Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

 

(7)Reflects Adjusted EBITDA / Net sales for the relevant periods.

 

 

 

 

CADRE HOLDINGS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES - CONTINUED

(Unaudited)

(In thousands)

 

   Year Ended December 31, 2020   Nine Months Ended September 30, 2020   Nine Months Ended September 30, 2021   LTM
September 30, 2021
 
(in thousands)                    
Net (loss) income  $38,453   $22,673   $8,373   $24,153 
Add back:                    
Depreciation and amortization   14,733    11,207    10,426    13,952 
Interest expense   24,388    18,275    14,129    20,242 
Provision for income taxes   (10,578)   1,491    3,861    (8,208)
EBITDA  $66,996   $53,646   $36,789   $50,139 
Add back:                    
Restructuring and transaction costs(1)   5,822    3,143    1,491    4,170 
Other general income(2)   (10,950)   (10,950)   -    - 
Loss on extinguishment of debt(3)   200    -    15,155    15,355 
Other (expense) income, net(4)   (2,659)   (1,925)   881    147 
Contingent consideration(5)   (1,427)   (1,427)   -    - 
LTIP bonus(6)   -    -    1,804    1,804 
Adjusted EBITDA  $57,982   $42,487   $56,120   $71,615 
Adjusted EBITDA margin   14.3%   14.3%   17.3%          

 

 


(1)Reflects the “Restructuring and transaction costs” line item on our consolidated statement of operations, which primarily includes transaction costs composed of legal and consulting fees.

 

(2)Reflects the “Other general income” line item on our consolidated statement of operations and includes a gain from a long-lived asset sale as well as earn-out stock payments for the nine months ended September 30, 2020.

 

(3)Reflects a loss incurred in connection with the August 2021 debt refinance.

 

(4)Reflects the “Other (expense) income, net” line item on our consolidated statement of operations. For the three and nine months ended September 30, 2021, other (expense) income, net primarily includes losses on foreign currency transactions. For the three and nine months ended September 30, 2020, other (expense) income, net primarily includes gains on foreign exchange transactions and unrealized gains on an investment in equity securities.

 

(5)Reflects a gain on the settlement of contingent consideration.

 

(6)Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

  

(7)Reflects Adjusted EBITDA / Net sales for the relevant periods.